2nd September 2021 | Pharma Updates

Centrient Pharma buys Astral SteriTech

The acquisition expands the drug maker portfolio with the best quality sterile injectable antibiotic finished dosage forms.

Brinton Pharma launches Hohner Health

Pharma Company named Brinton has launched the wellness and personal care brand, Hohner Health.

IPC flags side effects linked to Sofosbuvir

The Indian Pharmacopoeia Commission has issued a drug safety alert for revealing that Sofosbuvir is linked with the Stevens-Johnson Syndrome.

LIC buys more than 6.64 lakh shares of Cadila

Life Insurance Corporation of India has acquired 6.64 lakh shares of Cadila Healthcare through an open market transaction.

Pfizer’s Phase-III Jade trial shows positive results for atopic dermatitis

The study compares the efficiency of dupilumab and abrocitinib on atomic dermatitis in achieving near-complete skin clearance.

Empagliflozin reduces hospitization risk for cardiac and heart failure by 21 per cent

With approval, Empagliflozin would become the first and only clinically-proven treatment to improve outcomes for the full spectrum of heart failure patients, regardless of ejection fraction.

CELEBI Delhi achieves IATA CEIV pharma certification

Celebi Ground Handling and Celebi Delhi Cargo Terminal Management has been accredited with IATA CEIV Pharma certification for warehouse and cargo operations.